Oscar Health, Inc.
- Stock
- Ticker OSCR
- ISIN US6877931096
- NYSE
Performance, volatility and drawdowns of Oscar Health, Inc. since 03/2021, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $14,311. Global equities (VT): $14,653.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −94.2% in 12/2022, measured from the peak in 03/2021. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 2,392 | 3,046 | 2,864 | 2,986 | 2,805 | 4,647 | 4,880 | 5,139 |
| Operating income | -148 | 297 | -230 | -129 | -334 | 704 | 389 | 178 |
| EBITDA | -138 | 304 | -224 | -122 | -326 | 711 | 395 | 185 |
| Net income | -154 | 275 | -228 | -137 | -353 | 679 | 362 | 167 |
| Earnings per share | -0.55 | 0.92 | -0.89 | -0.53 | -1.34 | 2.07 | 1.10 | 0.49 |
| Balance sheet | ||||||||
| Total assets | 4,840 | 5,844 | 6,384 | 5,746 | 6,325 | 9,290 | 11,227 | 10,009 |
| Liabilities | 3,824 | 4,508 | 5,223 | 4,719 | 5,345 | 7,623 | 9,172 | 7,783 |
| Equity | 1,014 | 1,333 | 1,158 | 1,024 | 978 | 1,664 | 2,052 | 2,223 |
| Cash | 1,527 | 2,237 | 2,599 | 2,149 | 2,774 | 4,805 | 4,076 | 4,467 |
| Long-term debt | 300 | 300 | 300 | 686 | 430 | 431 | 432 | 432 |
| Cash flow | ||||||||
| Operating cash flow | 347 | 879 | 509 | -965 | 672 | 2,619 | 2,092 | -1,201 |
| Capital expenditure | -6.8 | -9.0 | -9.3 | -9.0 | -9.1 | -8.8 | -12 | -11 |
| Free cash flow | 340 | 870 | 500 | -974 | 663 | 2,610 | 2,081 | -1,212 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2023 at +272.0%, weakest 2022 at −68.7%. 3 of 4 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 5 Nov 2026 | $0.49 |
| 7 Aug 2026 | $1.10 |
| 7 May 2026 | $2.07 |
| 13 Feb 2026 | −$1.34 |
| 6 Nov 2025 | −$0.53 |
| 7 Aug 2025 | −$0.89 |
| 8 May 2025 | $0.92 |
| 20 Feb 2025 | −$0.55 |
| 7 Nov 2024 | −$0.22 |
| 7 Aug 2024 | $0.20 |
| 7 May 2024 | $0.62 |
| 15 Feb 2024 | −$0.67 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €7.8bn
- Market cap in trading currency
- $8.57bn
- Enterprise value
- $1.51bn
- P/E
- 10.7
- P/S
- 0.49
- P/B
- 3.85
- EV/Sales
- 0.09
- EV/EBITDA
- 1.6
- Earnings yield
- 9.4%
- FCF yield
- 48.3%
Results (last four quarters)
- Revenue
- $17.5bn
- Gross profit
- –
- EBITDA
- $964m
- Net income
- $855m
- Earnings per share
- $2.32
- Revenue per share
- $50.43
- Revenue growth
- +72.1%
- Earnings growth
- –
Profitability
- Gross margin
- –
- Operating margin
- 5.4%
- Net margin
- 4.9%
- Return on equity
- 52.7%
- Return on assets
- 8.5%
Balance sheet and cash flow
- Cash
- $7.49bn
- Cash per share
- $21.61
- Financial debt
- $432m
- Debt/equity %
- 19
- Current ratio
- 1.14
- Book value per share
- $6.42
- Operating cash flow
- $4.18bn
- Free cash flow
- $4.14bn
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- 0%
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 346m
- Volume
- 6.52m
- Avg. volume 3 months
- 5.24m
- Relative volume
- 1.2
Price and technicals
- Price
- $24.73
- 1 day
- −5.5%
- 52-week high
- $35.19
- 52-week low
- $10.85
- Distance to 52-week high
- −29.7%
- Distance to 52-week low
- +127.9%
- Distance to 50-day line
- −21.6%
- Distance to 200-day line
- −0.2%
- RSI (14)
- 30
- Volatility 1M
- 72.9%
Performance
- 1 week
- −20.4%
- 1 month
- −25.8%
- 3 months
- −22.3%
- 6 months
- +9.2%
- YTD
- +72.1%
- 1 year
- +75.6%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has OSCR performed since 03/2021?
$10,000 grew to $7,106 by 20 Nov 2026, which is −5.8% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is OSCR?
Volatility was 81.4% per year, measured on monthly returns. The largest decline from a peak was −94.2%, with the low in 12/2022.
How does OSCR compare with a broad equity ETF?
Over the same period Global equities (VT) returned +9.3% per year at 14.8% volatility, OSCR returned −5.8% at 81.4%. The correlation of monthly returns was 0.44; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.